Park West Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,123,052
Closed -$21.5M 57
2025
Q1
$21.5M Sell
1,123,052
-476,948
-30% -$14M 1.74% 25
2024
Q4
$57.6M Buy
1,600,000
+530,000
+50% +$17.9M 4.63% 4
2024
Q3
$45.4M Buy
1,070,000
+399,279
+60% +$16.9M 3.25% 14
2024
Q2
$27M Sell
670,721
-726,559
-52% -$30.3M 1.98% 20
2024
Q1
$49.5M Buy
+1,397,280
New +$37.4M 3.52% 11
2020
Q3
Sell
-150,000
Closed -$14.8M 101
2020
Q2
$14.8M Buy
+150,000
New +$12M 0.74% 43
2019
Q4
Sell
-550,000
Closed -$32.4M 84
2019
Q3
$32.4M Buy
+550,000
New +$35.1M 1.58% 23

Other funds holding TNDM

Park West Asset Management's TNDM Position: Q2 2025 in Review

Park West Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 1,123,052 shares — an estimated $21.5M sold.

Park West Asset Management first reported a position in TNDM in Q3 2019 and held it in 7 quarters. The position peaked at $57.6M in Q4 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Park West Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Park West Asset Management sold 1,123,052 Tandem Diabetes Care shares in Q2 2025, an estimated $21.5M.
  • Park West Asset Management first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 7 quarters.
  • Park West Asset Management's Tandem Diabetes Care position peaked at $57.6M in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Park West Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.